India mulls legal action against US think tank's 'smear' campaign
This article was originally published in Scrip
Executive Summary
Even as India's Prime Minister Narendra Modi is set to begin his high profile five-day visit to the US showcasing the country's best side to top global investors, senior government officials were engaged in a major fire-fighting exercise over allegations against the quality of medicines from India.